biomarker detection | GenomeWeb

biomarker detection

The company is in the beginning stages of product development, but is confident that it has a product that will be successful in the early diagnostics market. 

The researchers said the technique could be used to identify biomarkers specific to cancer or bacterial infection that are too small to detect by other methods. 

The certification covers the development, production, and distribution of in vitro diagnostics for autoimmune disease.

The study showed that introducing a synthetic molecule into the blood of mice could force cancer cells, but not normal cells, to express a detectable biomarker.

NEW YORK (GenomeWeb News) – Fluidigm and Olink Bioscience today announced a co-marketing deal that combines each other's technologies to enable the interrogation of 96 samples across 92 proteins in one run from one microliter of sample in less than one day.

NEW YORK (GenomeWeb News) – Nuclea Biotechnologies and the College of Nanoscale Science & Engineering (CNSE) of the State University of New York on Thursday announced a $1 million research partnership to develop and commercialize a high-throughput nanochip to analyze biomarkers associated wit

NEW YORK (GenomeWeb News) – The Centre of Excellence for the Prevention of Organ Failure (PROOF) and MRM Proteomics announced today that they will partner on proteomic-based diagnostic tests for patients with chronic organ diseases.

NEW YORK (GenomeWeb News) – Akrivis Technologies today said that it has inked an agreement with United States Biological to co-develop, manufacture, and sell research products based on Akrivis' Z-Tect technology.

NEW YORK (GenomeWeb News) – Cancer care firm N-of-One today announced a deal with Foundation Medicine to translate sequencing data into clinically relevant information.

While using stem cells allows Stemina to "make the tissue type of interest. It's an all-human system," and allows the firm to build "the best potential in vitro environment to study a particular question," its CEO said.

Pages

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.